Leon Caly

The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro

Leon Caly, Julian Druce, Mike Catton et al. · Antiviral Research · 2020 · 2.3K citations · Full text

Life Sciences, Infectious Diseases, Pharmacotherapy +12

SARS-coronavirus-2 replication in Vero E6 cells: replication kinetics, rapid adaptation and cytopathology

Natacha S. Ogando, Tim J. Dalebout, Jessika C. Zevenhoven-Dobbe et al. · Journal of General Virology · 2020 · 635 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17

Isolation and rapid sharing of the 2019 novel coronavirus ( <scp>SARS</scp> ‐CoV‐2) from the first patient diagnosed with <scp>COVID</scp> ‐19 in Australia

Leon Caly, Julian Druce, Jason Roberts et al. · The Medical Journal of Australia · 2020 · 352 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +16

SARS-CoV-2 Variants of Interest and Concern naming scheme conducive for global discourse

Frank Konings, Mark D. Perkins, Jens H. Kuhn et al. · Nature Microbiology · 2021 · 315 citations · Full text

Language Studies, Linguistics, Discourse Analysis +8

Tracking the COVID-19 pandemic in Australia using genomics

Torsten Seemann, Courtney R. Lane, Norelle L. Sherry et al. · Nature Communications · 2020 · 198 citations · Full text

Life Sciences, Bioinformatics, Infectious Diseases +14